Caricamento...
Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy
Cytotoxic chemotherapy after exposure to nivolumab (nivo), an anti-programmed death-1 (PD-1) antibody, has been associated with good response compared with historical data in various cancers including head and neck squamous cell carcinoma (HNSCC). In a previous report, different chemotherapy regimen...
Salvato in:
| Pubblicato in: | Int Cancer Conf J |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Singapore
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6498283/ https://ncbi.nlm.nih.gov/pubmed/31149554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13691-019-00360-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|